ArticleIrish veterinary journal2024
Eradication of bovine tuberculosis in Ireland: is it a case of now or never?
Article in Irish veterinary journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Bovine tuberculosis (TB) in herds with long-duration of official freedom during a period of national resurgence of infections.Irish veterinary journal · 2026Article
- Animals as overlooked victims and vectors of tuberculosis: review ofOne health advances · 2026Review
- Bayesian Modeling of Bovine Tuberculosis Prevalence for Enhanced Estimation and Control in Intensive Dairy Farms: A Longitudinal Decision-Support Tools for Veterinarians and Policymakers.Veterinary medicine international · 2026Article
- The genomic diversity and spatial patterns of Mycobacterium bovis in Ireland revealed by whole genome sequencing.Irish veterinary journal · 2025Article
- The European Union One Health 2024 Zoonoses Report.EFSA journal. European Food Safety Authority · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
There has been a sharp disimprovement in the bovine tuberculosis (bTB) situation in Ireland in recent years. This commentary argues for critical programme change in three overarching themes relevant to the Irish bTB eradication programme, if eradication is to be successful: (1) Limiting infection in cattle. Residual (hidden) infection is an important constraint to eradication, due to the use of imperfect diagnostic tests. This is resolved with a risk-based approach, as is widely used in other national programmes, and would impact herd management, cattle trade and regionalisation. (2) Limiting infection within and from wildlife. Infection in wildlife is a key feature of bTB in many countries, including Ireland. Early research with badger vaccination has been promising. However, wide-scale badger vaccination has proved logistically challenging, and research to monitor progress is underway. It is unlikely that badger vaccination, in addition to current cattle controls, will be sufficient to achieve bTB eradication. (3) Programme leadership, management, governance and cost-sharing. There are a number of substantial, seemingly intractable, issues relating to programme leadership, management, governance and cost-sharing which alone are sufficient to preclude any sustained move to eradication. International examples of success are available, with funding models being critical to progress. In these three themes, most of the constraints are non-technical. If difficult decisions are not taken and the status quo is allowed to continue, there is a risk that infection may establish in further wildlife species, which may make eradication unattainable. Current decisions (including inaction) will impact future generations, including the general public (through the Exchequer) and future farming families.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.